Artiva Biotherapeutics, Inc. (ARTV) › Operating Cash FlowArtiva Biotherapeutics, Inc. (ARTV) — Operating Cash FlowAnnual figures by period end, from SEC filings.2023-12-31: -$47.43M2024-12-31: -$55.03M2025-12-31: -$76.75M-$76.75M2023-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$76.75M—2026-03-10From 2025-01-012024-12-31-$55.03M—2026-03-10From 2024-01-012023-12-31-$47.43M—2025-03-24From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)